AXA/2025/FY/Earnings presentation (press): Difference between revisions

Content deleted Content added
doc_archive: refresh summary p1abw4
doc_archive: refresh summary p1abw4
Line 36:
* {{t|2|p1abw4-9tbw}} Business Performance
* Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk and Technology
* {{t|3|}} Financial Performance
* Alban de Mailly Nesle, Group CFO
* {{t|4|p1abw4-vacu}} France
Line 55:
* REVENUES
* {{t|€116|p1abw4-yxjw}}bn
* {{t|+6%|p1abw4-yutx}} vs {{t|FY24|p1abw4-ndok|Full year 2024}}
* {{t|UNDERLYING EARNINGS||Underlying earnings}}
* {{t|€8.4|p1abw4-oasi}}bn
* {{t|+6%|p1abw4-xtf8}} vs {{t|FY24|p1abw4-3bra|Full year 2024}}
* {{t|+9%|}} Excl. {{t|AXA IM|p1abw4-9cne|AXA Investment Managers}}
* {{t|UEPS|p1abw4-5ldr|Underlying earnings per share}}
* {{t|€3.86|p1abw4-l996}}
* {{t|+8%|p1abw4-dpes}} vs {{t|FY24|p1abw4-ul38|Full year 2024}}
* {{t|DIVIDEND|p1abw4-d0x9|Dividend}}{{fn ref|1|2=See glossary for terminologies and footnotes on page 36 & 37 of this document.}}
* {{t|€2.32|p1abw4-1cs9}}
* {{t|+8%|p1abw4-idom}} vs {{t|FY24|p1abw4-eqyj|Full year 2024}}
* SOLVENCY II RATIO
* {{t|224%|p1abw4-ts7x}}
* {{t|+9pts|}} {{t|FY25|p1abw4-f4de|Full year 2025}}
 
{{fn note|1=1|2=See glossary for terminologies and footnotes on page 36 & 37 of this document.}}
Line 84:
! style="text-align:right" | COMBINED RATIO
|-
| style="text-align:left" | {{t|P&;;C|p1abw4-b57v|Property & casualty}}
| style="text-align:left" | {{t|€58.0bn|p1abw4-jqov}} <br/> {{t|+5%|p1abw4-pawh}} vs {{t|FY24||Full year 2024}}
| style="text-align:right" | {{t|€5.9bn|p1abw4-1m4z}} <br/> {{t|+9%|p1abw4-0iy6}} vs {{t|FY24||Full year 2024}}
| style="text-align:right" | {{t|90.6%|p1abw4-v9el}} <br/> vs 91.0% {{t|FY24||Full year 2024}}
|-
| style="text-align:left" | LIFE
| style="text-align:left" | {{t|€37.5bn|p1abw4-qrrm}} <br/> {{t|+9%|p1abw4-0iy6}} vs {{t|FY24||Full year 2024}}
| style="text-align:right" | {{t|€2.7bn|p1abw4-j8uf}} <br/> {{t|+4%|p1abw4-z85f}} vs {{t|FY24||Full year 2024}}
| style="text-align:right" | —
|-
| style="text-align:left" | HEALTH
| style="text-align:left" | {{t|€19.0bn|p1abw4-okof}} <br/> {{t|+5%|p1abw4-bxk2}} vs {{t|FY24||Full year 2024}}
| style="text-align:right" | {{t|€0.8bn|p1abw4-xr40}} <br/> {{t|+17%|p1abw4-4l05}} vs {{t|FY24||Full year 2024}}
| style="text-align:right" | {{t|97.9%|p1abw4-w1gu}} <br/> vs 98.1% {{t|FY24||Full year 2024}}
|}
</div>
Line 152:
'''ARTIFICIAL INTELLIGENCE'''
* AI is a strategic technology, bringing major benefits to businesses
* Beyond increased efficiency, AI will transform access to insurance, product personalization, and the customer experience; {{t|AXA|p1abw4-scha|AXA}} wants to be firmly positioned in this evolution
* AI is already concretely improving pricing accuracy, underwriting quality, and claims management
 
Line 215:
|-
| style="text-align:left" | France<br/>(27% of total {{t|GWP|p1abw4-o4wo|Gross written premiums}}{{fn ref|1}})
| style="text-align:right" | {{t|€31bn|p1abw4-y899}}<br/>{{t|+6%|p1abw4-luln}}
| style="text-align:right" | {{t|€2.2bn|p1abw4-xvcn}}<br/>{{t|+7%|p1abw4-g633}}
|-
| style="text-align:left" | Europe<br/>(38% of total {{t|GWP|p1abw4-o4wo|Gross written premiums}}{{fn ref|1}})
| style="text-align:right" | {{t|€43bn|p1abw4-79dl}}<br/>{{t|+6%|p1abw4-luln}}
| style="text-align:right" | {{t|€3.5bn|p1abw4-efpj}}<br/>{{t|+9%|p1abw4-bwba}}
|-
| style="text-align:left" | {{t|AXA XL|p1abw4-z73y|AXA XL}}<br/>(17% of total {{t|GWP|p1abw4-o4wo|Gross written premiums}}{{fn ref|1}})
| style="text-align:right" | {{t|€19bn|p1abw4-kuuu}}<br/>{{t|+4%|p1abw4-7lte}}
| style="text-align:right" | {{t|€1.9bn|p1abw4-qdgj}}<br/>{{t|+9%|p1abw4-jxem}}
|-
| style="text-align:left" | {{t|Asia, Africa &amp; EME-LATAM||AXA Asia, Africa & EME-LATAM}}<br/>(18% of total {{t|GWP|p1abw4-o4wo|Gross written premiums}}{{fn ref|1}})
| style="text-align:right" | {{t|€20bn|p1abw4-2prq}}<br/>{{t|+13%|p1abw4-xzp6}}
| style="text-align:right" | {{t|€1.5bn|p1abw4-2vf0}}<br/>{{t|+6%|p1abw4-luln}}
|}
</div>
Line 255:
| style="text-align:left" | Investing to improve customer retention &amp; expanding distribution footprint
|-
| style="text-align:left" | {{t|AXA XL|p1abw4-18nd|AXA XL}} (Large &amp; Specialty)
| style="text-align:left" | Profitable growth with stable margins
| style="text-align:left" | Capitalizing on attractive growth opportunities and continued cycle management
Line 272:
 
'''Health'''
* {{t|2025|}}: Competitive advantages with innovative products integrating more prevention
* BEYOND {{t|2025|}}: Capitalizing on demand for health & protection while further improving our margins
 
'''Protection'''
* {{t|2025|}}: Continued strong commercial momentum, especially in Japan and Switzerland
* BEYOND {{t|2025|}}: Capitalizing on demand for health & protection while further improving our margins
 
'''G/A Savings'''
* {{t|2025|}}: Accelerating net flows in Savings at attractive margins
* BEYOND {{t|2025|}}: Capturing savings & retirement opportunity, sourcing best asset management products for our customers
 
{{fn note|1=1|2=See glossary for terminologies and footnotes on page 36 & 37 of this document.}}
Line 407:
! style="text-align:left" | In Euro billion
! class="col-s" style="text-align:right" | {{t|FY24|p1abw4-votc|Full year 2024}}
! class="col-s" style="text-align:right" | {{t|FY25||Full year 2025}}
! class="col-s" style="text-align:right" | Change
|-
Line 445:
|-
! style="text-align:left" | In Euro billion
! class="col-s" style="text-align:right" | {{t|FY24||Full year 2024}}
! class="col-s" style="text-align:right" | {{t|FY25||Full year 2025}}
! class="col-s" style="text-align:right" | Change
|-
Line 471:
|-
! style="text-align:left" | In Euro billion
! class="col-s" style="text-align:right" | {{t|FY25||Full year 2025}}
|-
| style="text-align:left" | Protection
Line 493:
</div>
 
* Net Flows vs {{t|FY24||Full year 2024}}
* {{t|€+5.4|p1abw4-cocg}}bn vs {{t|€+1.5|p1abw4-sgh7}}bn in {{t|FY24|p1abw4-votc|Full year 2024}}
 
Line 562:
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | {{t|Property &amp;;; Casualty|p1abw4-6pya|Property & casualty}}
| style="text-align:right" | {{t|5.5|p1abw4-2ag0}}
| style="text-align:right" | {{t|5.9|p1abw4-jzfe}}
| style="text-align:right" | {{t|+9%|p1abw4-5gmn}}
|-
| style="text-align:left" | {{t|Life &amp;;; Health|p1abw4-6pmh|Life & health}}
| style="text-align:right" | {{t|3.3|p1abw4-ij5y}}
| style="text-align:right" | {{t|3.5|p1abw4-q3s6}}
Line 787:
| style="text-align:left" | Impact of the the end of grandfathering period on January 1, {{t|2026|p1abw4-qfy6|Year 2026}}
| style="text-align:right" | <b>-10pts</b> to {{t|215%|p1abw4-ihxj}}
| style="text-align:left" | - Euro {{t|2.4|p1abw4-aw5q}} billion grandfathered debt no longer eligible as capital from January {{t|1|p1abw4-1vtn}}, {{t|2026|p1abw4-zc9z|Year 2026}}
|-
| style="text-align:left" | Impact of Solvency II revision to come into effect in 1Q27
Line 813:
 
'''SOLID AND DIVERSIFIED FRANCHISE{{fn ref|1}}'''
* {{t|&#35;1|p1abw4-g31e}} Health & Protection
* {{t|&#35;2|p1abw4-t1su}} {{t|Property & Casualty|p1abw4-8wpp|Property & casualty}}
* {{t|&#35;7|p1abw4-z6om}} Savings & Pensions
 
<div style="overflow-x:auto">
Line 839:
 
'''KEY FIGURES{{fn ref|2}}'''
* {{t|>8m|p1abw4-vyyf}} Retail clients{{fn ref|3|2=target of €5bn annually}}
* {{t|1|p1abw4-x9vp}} out of {{t|5|p1abw4-r2tj}} households insured by {{t|AXA|p1abw4-o92o|AXA}} in France
* {{t|2.5|p1abw4-dbhe}} contracts per client on average
* {{t|1|p1abw4-twwv}} out of {{t|3|p1abw4-qwel}} SMEs insured by {{t|AXA|p1abw4-alpi|AXA}} in France
* {{t|>6m|p1abw4-yfw3}} Employee Benefits beneficiaries
* {{t|1|p1abw4-dsag}} / minute commercial claims covered
* {{t|33,000|p1abw4-d1yd}} people working for {{t|AXA|p1abw4-xjjx|AXA}} in France
* {{t|>€10bn|p1abw4-q4y4}} invested in the economy
* {{t|€37|p1abw4-xvfc}}m claims paid per day on average
 
Line 854:
'''REVENUES'''
* {{t|€31|p1abw4-ryoe}}bn {{t|+6%|p1abw4-7pby}} vs. {{t|FY24|p1abw4-vwzt|Full year 2024}}
* {{t|P&C|p1abw4-76we|Property & casualty}} {{t|+7%|}}
* Health & Protection {{t|+4%|p1abw4-2ino}}
* Savings & Pensions {{t|+7%|}}
 
'''KEY TAKEAWAYS'''
Line 925:
| style="text-align:right" | <b>16%</b>
|-
| style="text-align:left" | CUMULATIVE CASH REMITTANCE BETWEEN 2024 AND {{t|2026||Year 2026}}{{fn ref|1|2=Cumulative cash remittance between 2024 and 2026}}
| style="text-align:right" | <b>&gt;€21bn</b>
| style="text-align:right" | <b>€14.6bn</b>
Line 932:
 
* Record results, at the top end of the {{t|target range|p1abw4-yg5j|Target range}} while enhancing reserve prudence
* Confident to deliver {{t|underlying EPS|p1abw4-de0k|Underlying earnings per share}} growth at the upper end of {{t|6%-8%|p1abw4-vkh3}} {{t|target range|p1abw4-twkx|Target range}} for {{t|2026||Year 2026}}
* Laying foundations for the next plan and confident in delivering sustainable earnings growth
 
Line 950:
 
'''MSCI'''
* {{t|2025|}} score: AAA
 
'''CDP'''
* {{t|2025|}} score: B
 
'''MORNINGSTAR SUSTAINALYTICS'''
* {{t|2025|}} ESG Risk Rating: {{t|17.0|p1abw4-lgy1}} – Low risk
 
'''FTSE RUSSELL An LSEG Business'''
* {{t|2025|}} score: {{t|4.3/5|p1abw4-z8e0}} in {{t|FTSE4Good|p1abw4-yy7v}} Index Series
 
{{chunk|doc=p1abw4|c=32|p=33}}
Line 1,006:
* {{t|1|p1abw4-jul2}}. {{t|FY25|p1abw4-vnif|Full year 2025}} {{t|gross written premiums|p1abw4-nxao|Gross written premiums}} excluding {{t|AXA IM|p1abw4-pjde|AXA Investment Managers}}, Holdings, {{t|AXA|p1abw4-nha5|AXA}} Assistance, and {{t|AXA|p1abw4-pj1x|AXA}} Liabilities Managers.
 
* {{t|1|}}. Change {{t|FY25||Full year 2025}} vs. {{t|FY24||Full year 2024}} at constant fx.
* {{t|2|p1abw4-vjoz}}. Includes {{t|AXA XL|p1abw4-s4u5|AXA XL}} Re premiums of {{t|€2.6|p1abw4-g38y}}bn.
 
* {{t|1|}}. Change {{t|FY25||Full year 2025}} vs {{t|FY24||Full year 2024}} at constant fx.
 
* {{t|1|p1abw4-unf7}}. Including both short-term and long-term Employee Benefits {{t|GWP|p1abw4-pvfy|Gross written premiums}} and {{t|other revenues|p1abw4-ldgp|Other revenue}}.
Line 1,024:
* {{t|1|p1abw4-wodi}}. Shareholders’ equity Group share.
 
* {{t|1|}}. Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of {{t|January 1, 2026|p1abw4-fqc0}}, as if the Solvency II revision had come into force on the same date.
 
* {{t|1|p1abw4-0te4}}. Sources: France Assureurs & Argus de l’assurance, {{t|2024|p1abw4-ljg4}} data.